Alex Starr

1.1k citations
25 papers · 936 indexed · h-index 16
Topics
HER2/EGFR in Cancer Research (10 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Glycosylation and Glycoproteins Research (4 papers)

In The Last Decade

Alex Starr

25 papers receiving 917 citations

Peers

Alex Starr
Comparison fields: 5 of 88
  • Molecular Biology 532
  • Oncology 350
  • Molecular Medicine 229
  • Cancer Research 111
  • Pulmonary and Respiratory Medicine 100
Replace Wenhao Guo with:
Wenhao Guo China
Ming‐Chung Jiang Taiwan
Matthew A. Bill United States
Diptendra Kumar Sarkar India
Martin Hibbs United Kingdom
Tamer E. Fandy United States
Baoan Chen China
Demetrio Gerace Italy
Chandra Prakash Prasad India
Xuejun Hu China
Alex Starr relative to Wenhao Guo China Wenhao Guo's profile →
Citations per field
00.5×2.5×
Wenhao Guo · 1×
Citations per year

Countries citing papers authored by Alex Starr

Since Specialization
Citations

This map shows the geographic impact of Alex Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Starr more than expected).

Fields of papers citing papers by Alex Starr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Starr. The network helps show where Alex Starr may publish in the future.

Co-authorship network of co-authors of Alex Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Starr. A scholar is included among the top collaborators of Alex Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Starr. Alex Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 38
2 21
3 15
4 25
5 6
6 16
7 50
8 18
9 54
10 40
11 134
12 95
13 14
14 119
15 3
16 2
17 53
18 65
19 7
20
OKT3-induced hypotension in heart allograft recipients treated for steroid-resistant rejection.
10

About Alex Starr

Alex Starr is a scholar working on Molecular Medicine, Oncology and Transplantation, having authored 25 papers that have together received 936 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Molecular Medicine (229 citations), Oncology (350 citations) and Molecular Biology (532 citations). Alex Starr has collaborated with scholars based in Israel, United States and Austria. Frequent co-authors include Rami Ben‐Yosef, Shahar Lev‐Ari, Akiva Vexler, Nadir Arber, Joel Greif, Dan Aderka, Eyal Sagiv, Timothy C. Wang, Uri Rozovski and Peter Altevogt. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026